MENU
SMRI
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

SMRI stock forecast, quote, news & analysis

The investment seeks to provide long-term capital appreciation... Show more

Category: #Mid-Cap Value
SMRI
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for SMRI with price predictions
Sep 11, 2026

SMRI in -0.88% downward trend, sliding for three consecutive days on September 10, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SMRI declined for three days, in 96 of 144 cases, the price declined further within the following month. The odds of a continued downward trend are 67%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SMRI moved out of overbought territory on September 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 16 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 62%.

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMRI as a result. In 29 of 45 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.

The Moving Average Convergence Divergence Histogram (MACD) for SMRI turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 31 similar instances when the indicator turned negative. In 17 of the 31 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMRI advanced for three days, in 174 of 204 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

SMRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 193 of 232 cases where SMRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Applied Materials (NASDAQ:AMAT), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), QUALCOMM (NASDAQ:QCOM), ConocoPhillips (NYSE:COP), Newmont Corp (NYSE:NEM), Bristol-Myers Squibb Co (NYSE:BMY), Valero Energy Corp (NYSE:VLO).

Industry description

The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.

Market Cap

The average market capitalization across the Bushido Capital US Equity ETF ETF is 83.43B. The market cap for tickers in the group ranges from 9.46B to 682.54B. XOM holds the highest valuation in this group at 682.54B. The lowest valued company is APTV at 9.46B.

High and low price notable news

The average weekly price growth across all stocks in the Bushido Capital US Equity ETF ETF was -2%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 35%. QCOM experienced the highest price growth at 8%, while AMGN experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Bushido Capital US Equity ETF ETF was 6%. For the same stocks of the ETF, the average monthly volume growth was -0% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 42
Price Growth Rating: 39
SMR Rating: 51
Profit Risk Rating: 51
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
SMRI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category MidCapValue

Profile
Details
Category
Mid-Cap Value
Address
Alpha Architect ETF Trust213 Foxcroft Road, Broomall, PennsylvaniaBroomall
Phone
N/A
Web
www.valueshares.com
SMRI in -0.88% downward trend, sliding for three consecutive days on September 10, 2026